Beverly Hills Private Wealth’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,897
Closed -$235K 341
2025
Q1
$235K Buy
3,897
+135
+4% +$8.7K 0.05% 309
2024
Q4
$257K Buy
3,762
+168
+5% +$11.7K 0.05% 289
2024
Q3
$258K Sell
3,594
-753
-17% -$53.1K 0.05% 290
2024
Q2
$301K Buy
4,347
+17
+0.4% +$1.24K 0.07% 273
2024
Q1
$347K Sell
4,330
-362
-8% -$32.3K 0.08% 252
2023
Q4
$514K Sell
4,692
-580
-11% -$60K 0.13% 162
2023
Q3
$532K Sell
5,272
-5,605
-52% -$644K 0.16% 141
2023
Q2
$1.25M Buy
10,877
+5,505
+102% +$672K 0.21% 113
2023
Q1
$558K Buy
5,372
+1,070
+25% +$103K 0.17% 134
2022
Q4
$381K Buy
+4,302
New +$357K 0.17% 133

Other funds holding CNMD

Beverly Hills Private Wealth's CNMD Position: Q2 2025 in Review

Beverly Hills Private Wealth sold out of CONMED (CNMD) in Q2 2025, closing a stake of 3,897 shares — an estimated $235K sold.

Beverly Hills Private Wealth first reported a position in CNMD in Q4 2022 and held it in 10 quarters. The position peaked at $1.25M in Q2 2023. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Beverly Hills Private Wealth reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Beverly Hills Private Wealth sold 3,897 CONMED shares in Q2 2025, an estimated $235K.
  • Beverly Hills Private Wealth first reported a position in CONMED in Q4 2022 and held it in 10 quarters.
  • Beverly Hills Private Wealth's CONMED position peaked at $1.25M in Q2 2023.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2025, filed 29 Jul 2025.